Renal tissue expression of EGF and EGF receptor after ischaemic tubular injury: an immunohistochemical study.
Rat kidneys undergoing tubular regeneration after ischaemic injury have been examined with regard to EGF, EGF receptor and vimentin, using immunohistochemical techniques. Renal ischaemia was induced in male Sprague-Dawley rats by 35-min clamping of renal arteries. Groups (n = 4-6) of experimental animals were killed at different time intervals (12, 24, 48, 72 h, 7 and 14 days) after reperfusion. One hour before sacrifice, each rat received i.p. 200 mg/kg 5-bromo-2'-deoxyuridine (BrdU) for the immunocytological demonstration of DNA synthesis. Renal necropsies were processed to reveal by immunohistochemistry EGF, EGF receptor, vimentin, and BrdU incorporated into DNA of S-phase cells. Tubular necrosis particularly involved proximal straight tubules in the outer stripe of the outer medulla and was followed by tubular regeneration, with a peak of cell proliferation at 48-72 h and an apparent dedifferentiation of tubular epithelium. As soon as 12 h after ischaemia, there was a substantial reduction of EGF immunostaining and the incidence of distal tubules showing EGF immunoreactivity reached a nadir at 48 h. In control kidneys, EGF receptor was mostly immunolocalized in proximal tubules although juxtaglomerular cells also exhibited immunolabelling. EGF receptor immunostaining in tubular epithelium showed no major change during the episode of tubular necrosis (12-24 h) but disappeared in tubular profiles undergoing regenerative hyperplasia (48-72 h). No vimentin immunostaining was found in tubules of control kidneys. Tubular epithelium remained mostly vimentin negative during the early phase of tubular necrosis/regeneration (12-72 h). By contrast, 7 days after ischaemia numerous dedifferentiated tubules expressed vimentin. In conclusion, tubular regeneration after ischaemia is associated with a typical sequence of transient events: (1) reduction of EGF immunostaining; (2) disappearance of EGF receptors during the mitogenic response; (3) expression of vimentin in tubular epithelium, and (4) return to a normal appearance.
Toubeau
G
G
Laboratory of Histology and Experimental Cytology, Faculty of Medicine, Mons-Hainaut University, Belgium.
Nonclercq
D
D
Zanen
J
J
Laurent
G
G
Schaudies
P R
PR
Heuson-Stiennon
J A
JA
D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D004247:DNA / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000032:analysis* / Q000276:immunology / Q000502:physiology*; D004848:Epithelium / Q000737:chemistry / Q000473:pathology / Q000648:ultrastructure; D066246:ErbB Receptors / Q000032:analysis* / Q000276:immunology / Q000502:physiology*; D007150:Immunohistochemistry; D007511:Ischemia / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D007687:Kidney Tubules, Proximal / Q000098:blood supply* / Q000737:chemistry* / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D014746:Vimentin / Q000032:analysis / Q000276:immunology
D014746:Vimentin; D004815:Epidermal Growth Factor; D004247:DNA; D066246:ErbB Receptors